Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association

LS Mehta, KE Watson, A Barac, TM Beckie, V Bittner… - Circulation, 2018 - Am Heart Assoc
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women's health. CVD and …

Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1

HM Chang, R Moudgil, T Scarabelli… - Journal of the American …, 2017 - jacc.org
Modern cancer therapy has successfully cured many cancers and converted a terminal
illness into a chronic disease. Because cancer patients often have coexisting heart …

[HTML][HTML] Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

G Curigliano, D Lenihan, M Fradley, S Ganatra… - Annals of …, 2020 - Elsevier
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

[HTML][HTML] Radiation-induced heart disease: a review of classification, mechanism and prevention

H Wang, J Wei, Q Zheng, L Meng, Y Xin… - … journal of biological …, 2019 - ncbi.nlm.nih.gov
With the increasing incidence of thoracic tumors, radiation therapy (RT) has become an
important component of comprehensive treatment. RT improves survival in many cancers …

Evaluation and management of patients with heart disease and cancer: cardio-oncology

J Herrmann, A Lerman, NP Sandhu, HR Villarraga… - Mayo Clinic …, 2014 - Elsevier
The care for patients with cancer has advanced greatly over the past decades. A
combination of earlier cancer diagnosis and greater use of traditional and new systemic …

Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment

F Cai, MAF Luis, X Lin, M Wang… - Molecular and …, 2019 - spandidos-publications.com
Anthracyclines are highly effective chemotherapeutic agents, used for a wide variety of
malignancies. Cardiotoxicity is a well‑recognized side effect of anthracycline therapy that …

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task …

JL Zamorano, P Lancellotti… - European heart …, 2016 - academic.oup.com
The task of developing CPG documents covers not only integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

SCAI expert consensus statement: evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory …

CA Iliescu, CL Grines, J Herrmann… - Catheterization and …, 2016 - Wiley Online Library
In the United States alone, there are currently approximately 14.5 million cancer survivors,
and this number is expected to increase to 20 million by 2020. Cancer therapies can cause …

Canadian Cardiovascular Society guidelines for evaluation and management of cardiovascular complications of cancer therapy

SA Virani, S Dent, C Brezden-Masley, B Clarke… - Canadian Journal of …, 2016 - Elsevier
Modern treatment strategies have led to improvements in cancer survival, however, these
gains might be offset by the potential negative effect of cancer therapy on cardiovascular …

Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención primaria de enfermedad cardiovascular en la mujer

MA Sueldo, MAM Rivera… - … de cardiología de …, 2022 - scielo.org.mx
Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención
primaria de enfermedad cardiovascular en la mujer SciELO - Scientific Electronic Library …